Indaptus Therapeutics Inc.
13F holders, Q4 2024 (December 31)20holders +2
2new positions
1sold out
1famous investor
$0.85avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Indaptus Therapeutics Inc. in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($216K), Investment House LLC ($84K) and Geode Capital Management, LLC ($69K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 1 | $19K |
All 13F filers, Q3 2024 → Q4 2024: 46,240 shares bought and 16,751 shares sold, net +29,489 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | No change | 256,265 | $216K |
| Investment House LLC | 0.00% | Add +0.2% | 100,176 | $84K |
| Geode Capital Management, LLC | 0.00% | Add +12.3% | 82,118 | $69K |
| Strategy Asset Managers LLC | 0.01% | No change | 45,336 | $38K |
| Pine Valley Investments Ltd Liability Co | 0.00% | Reduce -0.1% | 43,921 | $37K |
| Renaissance Technologies | 0.00% | Add +2.2% | 27,700 | $23K |
| Debussy Capital Management LP | 0.00% | No change | 24,000 | $22K |
| Susquehanna International Group, LLP | 0.00% | New | 17,829 | $15K |
| Two Sigma Securities, LLC | 0.00% | New | 16,620 | $14K |
| State Street Corp. | 0.00% | No change | 13,073 | $11K |
| SBI Securities Co., Ltd. | 0.00% | — | 3,900 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -27.0% | 3,513 | $3K |
| UBS Group AG | 0.00% | Add +383.3% | 2,523 | $2K |
| Morgan Stanley | 0.00% | No change | 884 | $744 |
| Bangor Savings Bank | 0.00% | No change | 400 | $337 |
| Wells Fargo & Company | 0.00% | No change | 64 | $54 |
| Bank of America Corp. | 0.00% | Add +1.7% | 61 | $51 |
| JPMorgan Chase & Co. | 0.00% | No change | 19 | $16 |
| Group One Trading LLC | 0.00% | No change | 7 | $6 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is INDAPTUS THERAPEUTICS INC's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.